AnGes partner Vasomune to present Tie2 agonist AV-001 data at NATO NSPA CBRN conference

• AnGes development partner Vasomune will present data on Tie2 receptor agonist AV-001 at the NATO NSPA CBRN Conference on Sept. 28-29, 2026.
• The conference will be held at NATO NSPA headquarters in Capellen, Luxembourg.
• The presentation will focus on pegevongitide (AV-001) as a dual-use candidate targeting vascular leak linked to ARDS and trauma-related shock.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AnGes Inc. published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.